However, no significant differences were observed between the two groups in terms of age, sex, liver disease etiology, Child–Pugh class, BCLC staging, levels of serum AFP, ALT, AST, total bilirubin, albumin, and platelet count, size of the main tumor, number of tumors, vascular invasion, previous TACE sessions, or length of hospital stay. This evidence concerns the gene GPT and liver disorder.